Recent research in Nature Genetics reveals pervasive biases in GWAX studies using parental history of Alzheimer’s, ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab ...

Alzheimer’s is a devastating brain disease that affects nearly seven million Americans, but sometimes, it’s misdiagnosed.

As the days get shorter and cold winter weather comes, it can be dangerous for those with Alzheimer’s Disease and dementia ...

Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs, has announced its ...

The U.S. Senate recently passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act of 2024, bipartisan legislation. The original bill signed into law in 2018 ...

New research reveals that glyphosate, a widely used herbicide, can cause lasting brain inflammation and accelerate ...

A new study presented at the Radiological Society of North America annual meeting explored the link between obesity and the ...

Researchers discover a link between visceral fat around the midsection and an increased risk of developing Alzheimer’s.

Inhibiting TLR7, an immune signaling protein, may help preserve the protective layer surrounding nerve fibers in the brain ...

NASHVILLE, Tenn. (WSMV) -Starting Thursday December 5, the holiday musical “Christmas in Paradise” will run at the Franklin ...

The research, which appears today in the Journal of Neuroinflammation, identifies an association between glyphosate exposure ...